Cargando…
Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs
| Autores principales: | , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796337/ https://www.ncbi.nlm.nih.gov/pubmed/35661175 http://dx.doi.org/10.1111/all.15401 |
| _version_ | 1784860461157580800 |
|---|---|
| author | Watanabe, Masato Nakamoto, Keitaro Inui, Toshiya Sada, Mitsuru Chibana, Kazuyuki Miyaoka, Chika Yoshida, Yuki Aso, Jumpei Nunokawa, Hiroki Honda, Kojiro Nakamura, Masuo Tamura, Masaki Hirata, Aya Oda, Miku Takata, Saori Saraya, Takeshi Kurai, Daisuke Ishii, Haruyuki Takizawa, Hajime |
| author_facet | Watanabe, Masato Nakamoto, Keitaro Inui, Toshiya Sada, Mitsuru Chibana, Kazuyuki Miyaoka, Chika Yoshida, Yuki Aso, Jumpei Nunokawa, Hiroki Honda, Kojiro Nakamura, Masuo Tamura, Masaki Hirata, Aya Oda, Miku Takata, Saori Saraya, Takeshi Kurai, Daisuke Ishii, Haruyuki Takizawa, Hajime |
| author_sort | Watanabe, Masato |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9796337 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97963372022-12-30 Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs Watanabe, Masato Nakamoto, Keitaro Inui, Toshiya Sada, Mitsuru Chibana, Kazuyuki Miyaoka, Chika Yoshida, Yuki Aso, Jumpei Nunokawa, Hiroki Honda, Kojiro Nakamura, Masuo Tamura, Masaki Hirata, Aya Oda, Miku Takata, Saori Saraya, Takeshi Kurai, Daisuke Ishii, Haruyuki Takizawa, Hajime Allergy Letters John Wiley and Sons Inc. 2022-06-16 2022-10 /pmc/articles/PMC9796337/ /pubmed/35661175 http://dx.doi.org/10.1111/all.15401 Text en © 2022 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes. |
| spellingShingle | Letters Watanabe, Masato Nakamoto, Keitaro Inui, Toshiya Sada, Mitsuru Chibana, Kazuyuki Miyaoka, Chika Yoshida, Yuki Aso, Jumpei Nunokawa, Hiroki Honda, Kojiro Nakamura, Masuo Tamura, Masaki Hirata, Aya Oda, Miku Takata, Saori Saraya, Takeshi Kurai, Daisuke Ishii, Haruyuki Takizawa, Hajime Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs |
| title | Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs |
| title_full | Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs |
| title_fullStr | Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs |
| title_full_unstemmed | Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs |
| title_short | Soluble ST2 enhances IL‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs |
| title_sort | soluble st2 enhances il‐33–induced neutrophilic and pro‐type 2 inflammation in the lungs |
| topic | Letters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9796337/ https://www.ncbi.nlm.nih.gov/pubmed/35661175 http://dx.doi.org/10.1111/all.15401 |
| work_keys_str_mv | AT watanabemasato solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT nakamotokeitaro solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT inuitoshiya solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT sadamitsuru solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT chibanakazuyuki solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT miyaokachika solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT yoshidayuki solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT asojumpei solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT nunokawahiroki solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT hondakojiro solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT nakamuramasuo solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT tamuramasaki solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT hirataaya solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT odamiku solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT takatasaori solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT sarayatakeshi solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT kuraidaisuke solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT ishiiharuyuki solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs AT takizawahajime solublest2enhancesil33inducedneutrophilicandprotype2inflammationinthelungs |